Antidepressant Drugs Market is expected to reach a revenue of USD 26.9 Bn by 2033, at 3.3 percent CAGR Dimension Market Research
| MMDEX Fund | USD 51.23 0.30 0.58% |
Slightly above 62% of Praxis Growth's investor base is looking to short. The analysis of overall sentiment of trading Praxis Growth Index mutual fund suggests that many investors are alarmed at this time. Praxis Growth's investing sentiment can be driven by a variety of factors including economic data, Praxis Growth's earnings reports, geopolitical events, and overall market trends.
Praxis |
The antidepressant drugs market is set to experience significant growth in the coming years, driven by a rise in awareness of mental health, development in treatment options, and the growth of telehealth services. The development of innovative therapies, like fast-acting and personalized medications, along with an increase in the adoption of mental health treatment, will further propel market expansion and improve patient access.New York, Dec. 09, 2024 -- Overview The Antidepre
Read at finance.yahoo.com
 |
Praxis Growth Fundamental Analysis
We analyze Praxis Growth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Praxis Growth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Praxis Growth based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Praxis Growth is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Praxis Growth Index Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Praxis Growth mutual fund to make a market-neutral strategy. Peer analysis of Praxis Growth could also be used in its relative valuation, which is a method of valuing Praxis Growth by comparing valuation metrics with similar companies.
Peers
Praxis Growth Related Equities
| UIPMX | Precious Metals | 2.56 | ||||
| GLRBX | James Balanced | 0.48 | ||||
| GCEBX | Goldman Sachs | 0.69 | ||||
| FRGOX | Franklin Gold | 2.61 | ||||
| USERX | Gold | 3.05 | ||||
| EPGFX | Europac Gold | 3.56 | ||||
| OGMCX | Oppenheimer Gold | 3.63 |
Other Information on Investing in Praxis Mutual Fund
Praxis Growth financial ratios help investors to determine whether Praxis Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Praxis with respect to the benefits of owning Praxis Growth security.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |